Filing Details
- Accession Number:
- 0001127602-20-017158
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 16:18:25
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 16:18:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1767215 | W Joseph Laplume | 251 Ballardvale Street Wilmington MA 01887 | Evp, Corp Strategy & Develop | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-15 | 3,350 | $73.70 | 22,405 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-15 | 3,000 | $88.05 | 25,405 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-15 | 10,519 | $168.00 | 14,886 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 4,899 | $168.81 | 9,987 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-18 | 350 | $174.65 | 9,637 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2020-05-15 | 3,350 | $0.00 | 3,350 | $73.70 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2020-05-15 | 3,000 | $0.00 | 3,000 | $88.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-26 | 2021-02-26 | No | 4 | M | Direct |
| 3,985 | 2018-02-24 | 2022-02-24 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $167.54 to $168.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $168.605 to $169.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $174.62 to $174.6858. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
